b12 injections and drinking alcohol Vitamin in Fort Lauderdale Urban Recovery

It is the first membrane-permeable, selective inhibitor of nicotinamide N-methyltransferase (NNMT), developed at the University of Texas in 2017

By blocking NNMT activity, the compound preserves nicotinamide availability for the NAD+ salvage pathway, leading to 1.2- to 1.6-fold increases in intracellular NAD+ concentrations

Research into this peptide has shown some patients experiencing significant weight loss thanks to this peptide

Research has demonstrated that the compound shows anti-proliferative activity in specific cancer cell lines, with HeLa cells showing concentration and time-dependent growth inhibition across a 0.1-500 M range while HEK-293 cells remain unaffected

Follow-up labs help show whether the injection schedule is working